How Much Weight Can I Lose with Semaglutide?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by reducing hunger signals in your brain and slowing stomach emptying, which leads to lower calorie intake without feeling deprived. Clinical evidence shows participants lose an average of 15 to 22 percent of their body weight, though individual results depend on your genetics, lifestyle, and treatment consistency. PlexusDx helps you find your optimal dose while keeping your price flat—ensuring you get results without surprise costs as your therapy advances.

Real Weight Loss Results from Semaglutide Clinical Studies

The STEP program, a series of large randomized controlled trials, tracked weight loss in over 4,500 adults taking semaglutide for 68 weeks. Participants receiving the highest dose lost an average of 22 percent of their starting weight, compared to just 2.4 percent in the placebo group. Those on lower doses still achieved 15 to 18 percent weight loss, demonstrating that meaningful results occur across the dosing spectrum.

Weight loss typically follows a predictable pattern: most patients see noticeable changes within 4 to 6 weeks, with steady progress continuing through month 4. After three months, the rate of weight loss often plateaus slightly but continues at a slower pace through month 16 and beyond. Real-world data outside clinical trials shows similar outcomes when patients remain consistent with injections and maintain basic dietary awareness.

Factors That Influence Your Individual Weight Loss Outcome

Your genetics play a major role in how effectively semaglutide works for you. The GLP1R gene variant (rs6923761) affects how your body responds to the medication, while FTO gene variations (rs9939609) influence your baseline appetite regulation and weight set point. PlexusDx offers the Precision Peptide Genetic Test to map your peptide pathways and identify which compounds and doses align with your unique biology.

Beyond genetics, your starting weight, current activity level, and baseline metabolic rate shape your weight loss timeline. Patients starting at higher weights often experience larger absolute pound loss, though percentage loss remains consistent. Combining semaglutide with moderate increases in daily movement and protein intake typically accelerates results, though the medication alone drives substantial reduction even without major lifestyle overhaul.

Timeline: When You'll See Weight Loss on Semaglutide

Weeks 1 to 2 mark the beginning of appetite suppression, though weight changes may not appear on the scale yet. By week 3 to 4, most patients notice reduced food cravings and portion sizes shrinking naturally. The first visible weight loss typically appears between weeks 4 and 8, with an average loss of 3 to 5 pounds during this initial phase.

Months 2 through 4 bring accelerated weight loss, with many patients losing 1 to 2 pounds per week during peak response. By month 4, cumulative loss often ranges from 10 to 15 pounds. From month 4 onward, weight loss continues but at a gentler pace as your body adapts; steady progress of 0.5 to 1 pound weekly continues through month 6 and beyond, with total reductions reaching 20 to 30 pounds or more depending on starting weight and adherence.

Maximizing Weight Loss: Dosing, Consistency, and Personalization

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with flat pricing across commitment tiers—meaning your dose may increase but your monthly cost stays the same. Higher doses correlate with greater weight loss in studies, but the most effective dose is one you can tolerate consistently without intolerable side effects. Your provider works with you to find the sweet spot where appetite suppression is powerful and gastrointestinal effects remain manageable.

Consistency matters more than perfection. Skipping injections or inconsistent timing reduces the compound's effectiveness and may slow weight loss by several pounds per month. PlexusDx services all 50 states without insurance requirements, and all medications come from licensed 503A compounding pharmacies, ensuring purity and potency. For patients who want genetic insights into their peptide pathways, the Precision Peptide Genetic Test ($298) reveals your GIPR, FTO, and MC4R variants, enabling truly personalized therapy selection and dose optimization.

Comparing Semaglutide to Other GLP-1 Options

Semaglutide's weight loss profile is well-established, but tirzepatide (which targets two peptide pathways instead of one) shows slightly higher average weight loss in head-to-head trials: 20 to 24 percent compared to semaglutide's 15 to 22 percent. However, semaglutide often produces these results with fewer gastrointestinal side effects, making it ideal for patients prioritizing tolerability. PlexusDx offers both as separate injectables or combined in the GLP-Squared formula, allowing flexibility based on your response and preferences.

Oral formulations of both semaglutide and tirzepatide are available through PlexusDx but deliver lower systemic absorption than injections, typically resulting in 5 to 10 percent less weight loss overall. The choice between oral and injectable depends on your comfort level and priority: injections offer maximum efficacy, while oral options suit patients who prefer tablet convenience. Your provider can adjust this decision after your first month based on your initial response and genetic test results if available.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I expect to lose 30 pounds or more with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How does semaglutide actually cause weight loss?

Semaglutide activates GLP-1 receptors in your brain's appetite center, reducing hunger signals and increasing fullness after smaller meals. It also slows how fast your stomach empties, prolonging satiety and lowering total calorie intake. This mechanism produces weight loss without requiring willpower or strict dieting, though combining it with protein-rich foods and basic movement enhances results.

What does semaglutide cost at PlexusDx, and how does pricing work?

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with flat pricing across all commitment tiers—your dose can increase as needed, but your monthly cost won't change. Oral Semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan). All medications are HSA/FSA eligible, require no insurance or membership fee, and ship to all 50 states from licensed 503A compounding pharmacies.

What side effects might slow my weight loss progress?

Nausea, constipation, and reduced appetite can temporarily limit food intake in early weeks, but these typically resolve within 4 to 8 weeks as your body adapts. Severe nausea may require a dose reduction, which slows weight loss slightly but allows long-term consistency. Staying hydrated, eating smaller protein-rich meals, and adding fiber gradually minimizes GI effects and keeps weight loss on track.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (FTO) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.